- Home
- GDEV vs NXPLW Comparison
GDEV vs NXPLW Comparison
Compare GDEV & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDEV
- NXPLW
- Stock Information
- Founded
- GDEV 2009
- NXPLW N/A
- Country
- GDEV Cyprus
- NXPLW United States
- Employees
- GDEV N/A
- NXPLW 166
- Industry
- GDEV EDP Services
- NXPLW Telecommunications Equipment
- Sector
- GDEV Technology
- NXPLW Telecommunications
- Exchange
- GDEV Nasdaq
- NXPLW Nasdaq
- Market Cap
- GDEV N/A
- NXPLW N/A
- IPO Year
- GDEV N/A
- NXPLW N/A
- Fundamental
- Price
- GDEV $11.93
- NXPLW N/A
- Analyst Decision
- GDEV Buy
- NXPLW
- Analyst Count
- GDEV 2
- NXPLW 0
- Target Price
- GDEV $70.00
- NXPLW N/A
- AVG Volume (30 Days)
- GDEV 18.5K
- NXPLW 6.4K
- Earning Date
- GDEV 05-27-2025
- NXPLW 03-31-2025
- Dividend Yield
- GDEV N/A
- NXPLW N/A
- EPS Growth
- GDEV N/A
- NXPLW N/A
- EPS
- GDEV 1.38
- NXPLW N/A
- Revenue
- GDEV $420,933,000.00
- NXPLW $66,482,000.00
- Revenue This Year
- GDEV $4.73
- NXPLW N/A
- Revenue Next Year
- GDEV $16.15
- NXPLW N/A
- P/E Ratio
- GDEV $8.64
- NXPLW N/A
- Revenue Growth
- GDEV N/A
- NXPLW 179.89
- 52 Week Low
- GDEV $8.60
- NXPLW $0.25
- 52 Week High
- GDEV $42.76
- NXPLW $0.26
- Technical
- Relative Strength Index (RSI)
- GDEV 46.25
- NXPLW N/A
- Support Level
- GDEV $8.81
- NXPLW N/A
- Resistance Level
- GDEV $14.20
- NXPLW N/A
- Average True Range (ATR)
- GDEV 1.14
- NXPLW 0.00
- MACD
- GDEV 0.39
- NXPLW 0.00
- Stochastic Oscillator
- GDEV 59.52
- NXPLW 0.00
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.